'Ares, HPS Line Up $3 Billion Debt for Carlyle's Baxter Unit Bid' - Bloomberg
$ARES
$BAX
$CG
Investment Managers
Finance
Medical/Dental Instruments
Health Care
Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 9/12/2024 | $42.00 | Equal Weight | Wells Fargo | |
| 9/12/2024 | $156.00 | Equal Weight | Wells Fargo | |
| 8/27/2024 | $55.00 | Buy | Redburn Atlantic | |
| 8/27/2024 | $140.00 | Neutral | Redburn Atlantic | |
| 8/6/2024 | $46.00 → $44.00 | Overweight → Neutral | JP Morgan | |
| 7/15/2024 | $39.00 → $30.00 | Equal-Weight → Underweight | Morgan Stanley | |
| 6/13/2024 | $176.00 → $132.00 | Buy → Hold | Deutsche Bank | |
| 5/30/2024 | $36.00 | Neutral | Goldman |
Wells Fargo initiated coverage of Carlyle Group with a rating of Equal Weight and set a new price target of $42.00
Wells Fargo initiated coverage of Ares Management with a rating of Equal Weight and set a new price target of $156.00
Redburn Atlantic initiated coverage of Carlyle Group with a rating of Buy and set a new price target of $55.00
Ares Management Corporation (NYSE:ARES) today reported its financial results for its third quarter ended September 30, 2024. GAAP net income attributable to Ares Management Corporation was $118.5 million for the quarter ended September 30, 2024. On a basic and diluted basis, net income attributable to Ares Management Corporation per share of Class A and non-voting common stock was $0.55 for the quarter ended September 30, 2024. After-tax realized income was $316.0 million for the quarter ended September 30, 2024. After-tax realized income per share of Class A common stock was $0.95 for the quarter ended September 30, 2024. Fee related earnings were $339.3 million for the quarter ended Sep
DIVIDEND DECLARATIONS Ares Capital Corporation ("Ares Capital") (NASDAQ:ARCC) announced that its Board of Directors has declared a fourth quarter 2024 dividend of $0.48 per share. The fourth quarter 2024 dividend is payable on December 30, 2024 to stockholders of record as of December 13, 2024. SEPTEMBER 30, 2024 FINANCIAL RESULTS Ares Capital also announced financial results for its third quarter ended September 30, 2024. OPERATING RESULTS Q3-24(1) Q3-23(1) (dollar amounts in millions, except per share data) Total Amount Per Share Total Amount Per Share GAAP net income per share(2)(3) $ 0.62
NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Carlyle Credit Income Fund ("we," "us," "our," "CCIF" or the "Fund") (NYSE:CCIF) announced today that it will release financial results after market close on Wednesday November 20, 2024, for its fourth quarter and full year 2024. CCIF will host a conference call at 10:00 a.m. EDT on Thursday, November 21, 2024, to discuss the results. The conference call will be available via public webcast via a link on Carlyle Credit Income Fund's website at www.carlylecreditincomefund.com and will also be available on the website soon after the call's completion. About Carlyle Credit Income Fund Carlyle Credit Income Fund (NYSE:CCIF) is an externally manage
$12.3 Billion in New Commitments Closed in the Third Quarter, Reaching a Record of $44.5 Billion Closed in the 12 Months Ended September 30, 2024 NEW YORK, NY / ACCESSWIRE / November 1, 2024 / Ares Management Corporation (NYSE:ARES) announced today that funds managed by its Credit Group (collectively "Ares") closed approximately $12.3 billion in U.S. direct lending commitments across 86 transactions during the third quarter of 2024 and approximately $44.5 billion in direct lending commitments across 328 transactions in the 12 months ended September 30, 2024. The $44.5 billion of commitments over the 12-month period represents a new record for the U.S. Direct Lending business. Below is a desc
Ares Management Corporation (NYSE:ARES) today reported its financial results for its third quarter ended September 30, 2024. GAAP net income attributable to Ares Management Corporation was $118.5 million for the quarter ended September 30, 2024. On a basic and diluted basis, net income attributable to Ares Management Corporation per share of Class A and non-voting common stock was $0.55 for the quarter ended September 30, 2024. After-tax realized income was $316.0 million for the quarter ended September 30, 2024. After-tax realized income per share of Class A common stock was $0.95 for the quarter ended September 30, 2024. Fee related earnings were $339.3 million for the quarter ended Sep
Michael Smith and Mitch Goldstein Appointed as Co-Chairmen of Board of Directors Ares Capital Corporation ("Ares Capital") (NASDAQ:ARCC) announced today that James ("Jim") R. Miller was appointed as Co-President to serve alongside current Co-President, Kort Schnabel. Concurrently, Ares Capital's Board of Directors was expanded by one member. Mitchell ("Mitch") Goldstein joined Ares Capital's Board of Directors, and Mitch Goldstein and Michael L. Smith have been appointed to serve as Co-Chairmen of Ares Capital's Board of Directors. Michael Arougheti will cease to serve as Chairman of Ares Capital's Board of Directors but will continue to serve as a Director. Kipp deVeer will continue in hi
4 - Ares Management Corp (0001176948) (Issuer)
4 - Carlyle Group Inc. (0001527166) (Reporting)
4 - Ares Management Corp (0001176948) (Issuer)
SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)
SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)
SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)
8-K - Ares Management Corp (0001176948) (Filer)
8-K - Ares Management Corp (0001176948) (Filer)
CERT - Ares Management Corp (0001176948) (Filer)
Michael Smith and Mitch Goldstein Appointed as Co-Chairmen of Board of Directors Ares Capital Corporation ("Ares Capital") (NASDAQ:ARCC) announced today that James ("Jim") R. Miller was appointed as Co-President to serve alongside current Co-President, Kort Schnabel. Concurrently, Ares Capital's Board of Directors was expanded by one member. Mitchell ("Mitch") Goldstein joined Ares Capital's Board of Directors, and Mitch Goldstein and Michael L. Smith have been appointed to serve as Co-Chairmen of Ares Capital's Board of Directors. Michael Arougheti will cease to serve as Chairman of Ares Capital's Board of Directors but will continue to serve as a Director. Kipp deVeer will continue in hi
Transaction Reinforces AIR's Presence in Europe and Enhances its Capabilities for Integration of Advanced Robotics into Automated Systems Vivian Farrell Promoted to President of Automated Industrial Robotics, Ireland Automated Industrial Robotics Inc. ("AIR" or the "Company") today announced the acquisition of Robotics & Drives ("RDS"), an Ireland-based industrial automation company focused on delivering innovative solutions through robotics technology. The transaction further reinforces AIR's presence in Europe, strengthens the Company's ability to integrate robotics solutions into its automated systems and adds to the product portfolio. The transaction was funded primarily by an additio
London, UK and New York, USA, September 10, 2024 - Abingworth, a leading transatlantic life sciences investment firm and part of global investment firm Carlyle (NASDAQ:CG), today announced the appointment of Robert (Bob) DeBenedetto as Managing Director – Clinical Co-Development. Bob brings to Abingworth over 30 years of experience in the life sciences industry and will be working on Clinical Co-Development deals and execution with new and existing Abingworth portfolio companies. He will be based in Abingworth's Menlo Park, CA, USA office. Prior to joining Abingworth, Bob was the Founder, President and CEO of SFJ Pharmaceuticals Inc. (CA, USA), an Abingworth portfolio company, where he
4 - Ares Management Corp (0001176948) (Reporting)
4 - Ares Management Corp (0001176948) (Reporting)
4 - Ares Management Corp (0001176948) (Reporting)
Ares Management Corp. (NYSE:ARES) and HPS Investment Partners are spearheading a $3 billion credit facility to finance Carlyle Group Inc.’s (NASDAQ:CG) potential acquisition of Baxter International Inc.’s (NYSE:BAX) kidney-care division. This debt package includes a $2.5 billion unitranche loan and a $450 million revolver. Oaktree Capital Management is also involved in the financing, and smaller lenders may participate after signing. Also Read: Medical Devices Giant Baxter Secures FDA Approval For New Infusion Pump System. The financing terms suggest an interest rate five percentage points above the Secured Overnight Financing Rate, placing the division Vantive’s leverage at 4.2
https://www.bloomberg.com/news/articles/2024-07-23/ares-hps-line-up-3-billion-debt-for-carlyle-s-baxter-unit-bid?sref=y3YMCJ4e
Directors Robert Langer and Stephen Berenson will also retire from the Board.
For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c